Bluejay Diagnostics, Inc. (BJDX)
1.94
-0.05
(-2.51%)
USD |
NASDAQ |
Feb 20, 13:14
Bluejay Diagnostics Shareholders Equity (Quarterly) : 3.693M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 598.36M |
| Plus Therapeutics, Inc. | 5.054M |
| Atossa Therapeutics, Inc. | 49.79M |
| Abeona Therapeutics, Inc. | 171.23M |
| Cell Source, Inc. | -18.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.890M |
| Total Liabilities (Quarterly) | 1.198M |
| Debt to Equity Ratio | 0.0415 |
| Current Ratio | 2.830 |
| Net Debt Paydown Yield | 2.32% |